Owens & Minor Total Assets 2006-2019 | OMI

Owens & Minor total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Owens & Minor Annual Total Assets
(Millions of US $)
2018 $3,774
2017 $3,376
2016 $2,718
2015 $2,774
2014 $2,735
2013 $2,324
2012 $2,214
2011 $1,947
2010 $1,822
2009 $1,747
2008 $1,776
2007 $1,528
2006 $1,686
2005 $1,240
Owens & Minor Quarterly Total Assets
(Millions of US $)
Q1 2019 $3,882
Q4 2018 $3,774
Q3 2018 $4,032
Q2 2018 $4,043
Q1 2018 $3,392
Q4 2017 $3,376
Q3 2017 $3,334
Q2 2017 $2,795
Q1 2017 $2,701
Q4 2016 $2,718
Q3 2016 $2,795
Q2 2016 $2,756
Q1 2016 $2,797
Q4 2015 $2,774
Q3 2015 $2,752
Q2 2015 $2,795
Q1 2015 $2,700
Q4 2014 $2,735
Q3 2014 $2,944
Q2 2014 $2,364
Q1 2014 $2,369
Q4 2013 $2,324
Q3 2013 $2,348
Q2 2013 $2,379
Q1 2013 $2,321
Q4 2012 $2,214
Q3 2012 $2,222
Q2 2012 $1,955
Q1 2012 $1,925
Q4 2011 $1,947
Q3 2011 $1,950
Q2 2011 $1,906
Q1 2011 $1,911
Q4 2010 $1,822
Q3 2010 $1,841
Q2 2010 $1,805
Q1 2010 $1,749
Q4 2009 $1,747
Q3 2009 $1,697
Q2 2009 $1,689
Q1 2009 $1,687
Q4 2008 $1,776
Q3 2008 $1,572
Q2 2008 $1,586
Q1 2008 $1,537
Q4 2007 $1,528
Q3 2007 $1,568
Q2 2007 $1,640
Q1 2007 $1,682
Q4 2006 $1,686
Q3 2006 $1,455
Q2 2006 $1,306
Q1 2006 $1,275
Q4 2005 $1,240
Q3 2005 $1,231
Q2 2005 $1,186
Q1 2005 $1,171
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.192B $9.839B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.709B 28.48
Medtronic (MDT) Ireland $133.941B 19.13
Stryker (SYK) United States $76.636B 27.35
Boston Scientific (BSX) United States $58.213B 27.91
Baxter (BAX) United States $41.870B 26.39
EssilorLuxottica Societe Anonyme (ESLOY) France $28.961B 0.00
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.277B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.004B 16.06
Terumo (TRUMY) Japan $22.862B 26.29
Smith & Nephew SNATS (SNN) United Kingdom $19.073B 0.00
ResMed (RMD) United States $17.690B 33.80
Canopy Growth (CGC) Canada $12.296B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.220B 48.88
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Aurora Cannabis (ACB) Canada $7.261B 71.60
Insulet (PODD) United States $7.142B 520.35
Hill-Rom Holdings (HRC) United States $7.099B 21.52
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.283B 51.28
ICU Medical (ICUI) United States $5.126B 30.59
GW Pharmaceuticals (GWPH) United Kingdom $5.014B 0.00
Neogen (NEOG) United States $3.340B 54.31
Hutchison China MediTech (HCM) China $2.954B 0.00
NuVasive (NUVA) United States $2.945B 24.05
Agios Pharmaceuticals (AGIO) United States $2.762B 0.00
National Vision Holdings (EYE) United States $2.459B 52.40
Quidel (QDEL) United States $2.264B 23.50
Aphria (APHA) $1.581B 0.00
Cardiovascular Systems (CSII) United States $1.532B 879.80
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.186B 0.00
VAREX IMAGING (VREX) United States $1.172B 24.87
Lantheus Holdings (LNTH) United States $1.081B 28.70
NanoString Technologies (NSTG) United States $1.069B 0.00
PetIQ (PETQ) United States $1.001B 24.32
Quanterix (QTRX) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Cerus (CERS) United States $0.757B 0.00
Omeros (OMER) United States $0.747B 0.00
MacroGenics (MGNX) United States $0.742B 0.00
TG Therapeutics (TGTX) United States $0.693B 0.00
LeMaitre Vascular (LMAT) United States $0.583B 28.24
Surmodics (SRDX) United States $0.531B 77.12
OraSure Technologies (OSUR) United States $0.527B 24.26
Meridian Bioscience (VIVO) United States $0.487B 14.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.393B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.53
BioLife Solutions (BLFS) United States $0.311B 97.35
Zynex (ZYXI) United States $0.239B 24.53
Cytosorbents (CTSO) United States $0.232B 0.00
Bovie Medical (APYX) United States $0.228B 0.00
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.173B 0.00
Female Health (VERU) United States $0.147B 0.00
Fonar (FONR) United States $0.137B 7.22
Chembio Diagnostics (CEMI) United States $0.101B 0.00
United-Guardian (UG) United States $0.094B 20.60
InfuSystems Holdings (INFU) United States $0.092B 0.00
Surface Oncology (SURF) United States $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 21.58
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00